Merck Serono Targets Japan's Underdeveloped Fertility Market, Builds Line Extensions On Vital Products
This article was originally published in PharmAsia News
Executive Summary
TOKYO - The pharmaceutical market in Japan is the world's second-largest, but most large companies are pretty well saturated here. Many companies now tout growth projections in China, drawing the regional spotlight away from Japan. But Merck Serono is aggressively promoting its products in Japan, trying to make up for lost time